Population
From March 2021 until November 2021, a total of 336 participants underwent screening of whom 208 consented participation and were asked for their preference. Of these patients, 103 preferred RM and 102 preferred SC. Additionally, three patients without a specific preference were randomly assigned into to the RM (n = 2) and SC group (n = 1). In total, 202 patients were analyzed (RM n = 102, and SC n = 100). 